sb 203580 has been researched along with 1,3-dimethylthiourea in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (1,3-dimethylthiourea) | Trials (1,3-dimethylthiourea) | Recent Studies (post-2010) (1,3-dimethylthiourea) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 457 | 0 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramesh, G; Reeves, WB | 1 |
| Kim, JY; Ro, JY | 1 |
2 other study(ies) available for sb 203580 and 1,3-dimethylthiourea
| Article | Year |
|---|---|
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice.
Topics: Animals; Cell Line; Cisplatin; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Imidazoles; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Thiazoles; Thiourea; Tumor Necrosis Factor-alpha | 2005 |
Signal pathway of cytokines produced by reactive oxygen species generated from phorbol myristate acetate-stimulated HMC-1 cells.
Topics: Antioxidants; Free Radical Scavengers; Humans; Imidazoles; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Mast Cells; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Thiourea; Transcription Factors; Tumor Necrosis Factor-alpha | 2005 |